论文部分内容阅读
为了研究维拉帕米和卡托普利以及它们联合用药对休息和运动时血压与心率的影响,对30名有中度或重度高血压(舒张压15.33～17.33 kPa)的病人进行了双盲研究,这些病人随机分为2组。用30天安慰剂无效后,A组15名病人(平均年龄60.6±8岁,血压27.60±1.9/16.13±0.7kPa),在第1个与第2个月分别用维拉帕米120mg,2次/d和240mg,2次/d。B组15名病人(平均年龄58.4.10岁,血压26.80±2.0/16.27±0.5kPa),以同样方法用卡托普利25 mg,
Thirty patients with moderate or severe hypertension (diastolic pressure 15.33-17.33 kPa) were double-blind in order to study the effects of verapamil and captopril and their combination therapy on blood pressure and heart rate during rest and exercise. Study, these patients were randomly divided into two groups. After 30 days of placebo discontinuation, 15 patients in group A (mean age 60.6 ± 8 years and 27.60 ± 1.9 / 16.13 ± 0.7 kPa in blood pressure) were treated with verapamil 120 mg at 2 and 1 month Times / d and 240mg, 2 times / d. B group of 15 patients (mean age 58.4.10 years, blood pressure 26.80 ± 2.0 / 16.27 ± 0.5kPa), the same method with captopril 25 mg,